Genetic variants in the GLP1R gene (e.g., rs6923761), GIPR receptor (rs1800437), FTO (rs9939609), and MC4R (rs17782313) influence appetite signaling, energy expenditure, and medication responsiveness
Where do you take your cut on your overexpenditure
Formula: 100 100 5 = 5.0 mg
Although no current evidence suggests that GLP-1RAs induce -catenin mutations or APC deficiencies, it is hypothesized that prolonged use of GLP-1RAs may foster the proliferative progression of colorectal cancer cells and pancreatic -cells, based on their mechanisms of action [99]
Evidence and Guidance Weight loss injections such as semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Mounjaro) are increasingly prescribed in the UK for weight management